Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis

Researchers suggest that patients taking isotretinoin are at much higher risk of inflammatory bowel disease, according to a study published in the American Journal of Gastroenterology.

Advertisement

The study assessed 3,664 cases of Crohn’s disease; 4,428 cases of ulcerative colitis; 97 cases of inflammatory bowel disease and 21,832 control cases. Of the total study population, 24 cases and 36 control were exposed to isotretinoin, which is used for treatment of acne.

Results showed that ulcerative colitis had a strong association with previous isotretinoin exposure. On the other hand, there was not as strong of an association between isotretinoin and Crohn’s disease.

 

Read the study about isotretinoin.

 

Read other coverage about GI conditions:

 

Exercise, Vitamin D Keys to Reducing GI Disease, Conditions

 

Surgeons Use Transoral Incisionless Fundoplication to Treat GERD

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.